Progenbiolab Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 5 Year, 25 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 148.59%
(FY 2022)
- Profit -75.64%
(FY 2022)
- Ebitda 1190.01%
(FY 2022)
- Net Worth 13.07%
(FY 2022)
- Total Assets 22.68%
(FY 2022)
About Progenbiolab Technologies
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Reetesh Vishwakarma and Bharti Vishwakarma serve as directors at the Company.
- CIN/LLPIN
U33208DL2019PTC358309
- Company No.
358309
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Dec 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Progenbiolab Technologies Private Limited offer?
Progenbiolab Technologies Private Limited offers a wide range of products and services, including Inspection & Quality Check Services, Food Certification Services, Autoclaves, Sterilizers & Incubators, UV Sterilizer and Lamps, Rapid Test Kit, Elisa Kits, Diagnostic Test Kit, Material Testing Labs & Services, Food testing services, Medical Laboratory Instruments.
Who are the key members and board of directors at Progenbiolab Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Reetesh Vishwakarma  | Director | 03-Dec-2019 | Current |
| Bharti Vishwakarma | Director | 03-Dec-2019 | Current |
Financial Performance of Progenbiolab Technologies.
Progenbiolab Technologies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 148.59% increase. The company also saw a substantial fall in profitability, with a 75.64% decrease in profit. The company's net worth Soared by an impressive increase of 13.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Progenbiolab Technologies?
Unlock access to Progenbiolab Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Progenbiolab Technologies?
Unlock and access historical data on people associated with Progenbiolab Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Progenbiolab Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Progenbiolab Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
